Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor

Table 2 Ingenuity pathways analysis

Diseases and disorders
Name	p-value	Molecules
Genetic Disorder	4,26E-09 - 1,42E-02	139
Cancer	2,72E-05 - 1,42E-02	91
Connective Tissue Disorders	4,26E-09 - 1,42E-02	57
Developmental Disorder	2,22E-06 - 1,42E-02	32
Dermatological Diseases and Conditions	3,49E-08 - 1,42E-02	29
Molecular and cellular functions
Name	p-value	Molecules
Cellular Growth and Proliferation	5,25E-06 - 1,42E-02	75
Gene Expression	1,28E-08 - 1,42E-02	67
Cellular Development	6,24E-09 - 1,42E-02	63
Cell Cycle	2,80E-06 - 1,42E-02	32
DNA Replication, Recombination, and Repair	2,71E-06 - 1,42E-02	15

List of Ingenuity Networks and Biological Functions from predicted targets of miRNA differentially expressed during EGF treatment.

ISSN: 1471-2164